Portfolio company Alto Neuroscience in the news: Crunchbase article “Alto Neuroscience Emerges From Stealth With $40M Aimed At Matching Patients And Drugs”

The greatest return is serving those who put their lives on the line: our nation’s high-risk public servants.

Linkedin-in

Risk & Return 2021. All rights reserved.